| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.008 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.009 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.009 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.01 |